Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03330197
Title A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors or DIPG
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Ziopharm
Indications
Therapies
Age Groups: child | adult
Covered Countries USA


No variant requirements are available.